Oscar Health Inc. (OSCR) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Oscar Health Inc. (OSCR) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How OSCR Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $28.6M | 44% | -1386.2% | -$443.2M | $1.09B | -45% |
| FY 2024 | $20.6M | 44% | 278.3% | $25.4M | $977.3M | 95% |
| FY 2023 | $21.4M | 44% | -1103.4% | -$270.7M | -$273.1M | -5.9% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring OSCR)
- ✓Live walkthrough of OSCR's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
OSCR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +39.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on OSCR today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for OSCR. Explore sector supply chains on /butterfly.
OSCR Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Oscar Health Inc. (OSCR)?
In FY 2025 (10-K), OSCR converted $28.6M of revenue into a 44% gross margin, 0% operating margin, and $1.1B in free cash flow (3824.6% FCF margin).